Results of prescription use of pulse ultrasound therapy in fracture management.
As of October 17, 1994,a pulsed ultrasound device has been used on a prescription basis by orthopaedic surgeons in the United States (Fig. 1). The Food and Drug Administration released this device for use in fresh tibial diaphysis and fresh distal radial metaphysis fractures. A patient registry that records all clinical data concerning both on-label and off-label prescription use of ultrasound, including other bones and different durations of fracture age, has been analyzed, Table 1 summarizes the data from October 17, 1994 to July 14, 1997. The overall healing rate was 91.6%. This includes fresh, delayed, and nonunited fractures.